November 1, 2022
November 1, 2022 —
New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.
November 1, 2022
November 1, 2022 —
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed.
November 1, 2022
November 1, 2022 —
The U.S. National Science Foundation announced $30 million in research awards to support new interdisciplinary, fundamental research projects for the Emerging Frontiers in Research and Innovation (EFRI) program — 20 percent of the funding was awarded to UC San Diego researchers.
October 31, 2022
October 31, 2022 —
Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.
October 31, 2022
October 31, 2022 —
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.
October 28, 2022
October 28, 2022 —
One in every eight strokes at UC San Diego Health occur in an adult younger than 50.
October 28, 2022
October 28, 2022 —
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.
October 27, 2022
October 27, 2022 —
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
October 26, 2022
October 26, 2022 —
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
October 25, 2022
October 25, 2022 —
Building upon a long history, the UC San Diego has launched a new Human Milk Institute to accelerate research into the biology and therapeutic potential of human milk to prevent or treat both infant and adult diseases. The new institute is believed to be the first of its kind in the United States.
